Sinomed Neurovita Technology Inc.
Clinical trials sponsored by Sinomed Neurovita Technology Inc., explained in plain language.
-
New stent shows promise in restoring brain blood flow after stroke
Disease control CompletedThis study tested a new device called SINOMED SR, a stent used to remove blood clots in the brain during a stroke. It involved 218 adults who had a severe acute ischemic stroke and were treated within 24 hours of symptoms starting. The main goal was to see if the stent could safe…
Phase: NA • Sponsor: Sinomed Neurovita Technology Inc. • Aim: Disease control
Last updated May 26, 2026 06:23 UTC
-
New stent shows promise for brain aneurysm patients
Disease control CompletedThis study tested a special stent (a small mesh tube) placed inside a brain artery to treat wide-necked brain aneurysms (bulging blood vessels). The goal was to block blood flow into the aneurysm to prevent rupture. 143 adults with unruptured aneurysms took part. The main focus w…
Phase: NA • Sponsor: Sinomed Neurovita Technology Inc. • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
New brain aneurysm device shows promise in 203-patient trial
Disease control CompletedThis study tested a new device called SINOMED IAS for treating brain aneurysms (a bulging blood vessel in the brain that can burst). The trial included 203 adults aged 18 to 80 with wide-necked aneurysms. The main goal was to see how well the device blocked the aneurysm at 6 mont…
Phase: NA • Sponsor: Sinomed Neurovita Technology Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC